OR WAIT 15 SECS
Angie Drakulich was editorial director of Pharmaceutical Technology.
The National Institute for Bioprocessing Research and Training in Ireland and Waters are partnering on training and research to increase large-molecule characterization capacity and knowledge.
The National Institute for Bioprocessing Research and Training (NIBRT) in Ireland and Waters are partnering on training and research to increase large-molecule characterization capacity and knowledge, according to an NIBRT press release.
The two organizations established the Complete Product and Processing Characterization Facility for hands-on laboratory-based scientific training and retraining of “fit-for-purpose” biopharmaceutical analysis, including protein and peptide characterization. The goal of the facility is to provide comprehensive training of industry and governmental technicians and scientists in an effort to develop advanced biotherapeutic characterization Training on US and European drug regulations will also be offered. Finally, the partnership establishes NIBRT as a Waters Center of Innovation in the area of glycobiology research.
“Ireland is a leading location globally for the development and manufacture of complex biopharmaceutical drugs. This is due in large part to a sustained commitment to quality and compliance with the highest regulatory standards,” said NIBRT’s Interim Director Prof. Ian Marison.
“Through this lab and other collaborations, Waters will work with industry to improve the development of biopharmaceuticals and inform governments on the types of regulations that should be put in place,” said Mike Harrington, Waters vice-president, European Operations.